Caixin
Jun 23, 2022 03:27 AM
BUSINESS

Online Drug Sellers Lead China Tech Losses on Fears of Sales Ban

Weakness in pharmaceutical shares and concerns of a global recession led the Hang Seng Tech Index to a decline of 4.4%.
Weakness in pharmaceutical shares and concerns of a global recession led the Hang Seng Tech Index to a decline of 4.4%.

(Bloomberg) — Shares of China’s online drug sellers slumped in Hong Kong Wednesday after a media report renewed concerns that Beijing may ban third-party platforms from offering medicines over the internet.

Alibaba Health Information Technology Ltd. plunged 14%, and JD Health International Inc. tumbled 15%, wiping out three days of strong gains. Weakness in pharmaceutical shares and concerns of a global recession led the Hang Seng Tech Index to a decline of 4.4%.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code